Skip to content
PeptideTech
sign in
live113 compounds · 13 vendors listed · 5 graded · audit of 4 Nov 2026 · prices checked 18 Nov 2026independent · grades can’t be bought

research prices read 17 Nov 2026 · doses from cited sources only

Retatrutide cost per month at research prices

At the 12 mg once weekly used in the phase 3 trial (Phase 3 TRIUMPH-1 (NEJM 2026): 4, 9 or 12 mg weekly for 80 weeks), 30 days is 51.43 mg of Retatrutide: about $321 at the lowest in-stock research price per mg and $437 at the median, prices read 17 Nov 2026, before shipping.

$6.25lowest per mg2 vendors in stock
$8.50median per mg7 in-stock offers
$32130 days at 12 mg once weeklyat the lowest price per mg

cited doses, not advice

These are the amounts used in published labels and studies, each linked to its source, costed at research-market prices. They are not a recommended dose, and research compounds are not approved medicines.

30 days · amount × doses per week · lowest and median in-stock price per mg · before shipping and codes

Retatrutide cost by cited regimen

Retatrutide: cited regimens and their 30-day cost at current research prices
sourcedose30-day amountat lowest $/mgat median $/mg
Phase 3 TRIUMPH-1 (NEJM 2026): 4, 9 or 12 mg weekly for 80 weeksphase 3 trial · 2,339 adults with obesity, without diabetes (including subgroups of 574 with knee osteoarthritis and 243 with obstructive sleep apnea)12 mg once weeklysubcutaneous51.43 mg6 × 10mg vials$321$437
Phase 3 TRIUMPH-2 (Lancet 2026): obesity with type 2 diabetes, 4, 9 or 12 mg weeklyphase 3 trial · 1,152 adults with BMI 27 or higher and type 2 diabetes (HbA1c 6.5-10.5%)12 mg once weeklysubcutaneous51.43 mg6 × 10mg vials$321$437
Phase 2 (NEJM 2023): 12 mg weekly arm, started at 2 mgphase 2 trial · 338 adults with BMI 30 or higher (or 27 to under 30 with a weight-related condition), without diabetes12 mg once weeklysubcutaneous51.43 mg6 × 10mg vials$321$437

Cost = dose × administrations per week × 30/7 × price per mg. Weight-based, single-dose, infusion and as-needed regimens are not costed. Prices are in-stock US offers seen in the last 7 days, before shipping, tax and codes; the Retatrutide page lists each offer with its source date.

research market · not for human use

These vendors sell compounds as research chemicals. Most are not FDA-approved.

same compound

more on Retatrutide

short answers

Retatrutide cost questions

How much does Retatrutide cost per month?
At the 12 mg once weekly used in the phase 3 trial (Phase 3 TRIUMPH-1 (NEJM 2026): 4, 9 or 12 mg weekly for 80 weeks), 30 days is 51.43 mg of Retatrutide: about $321 at the lowest in-stock research price per mg and $437 at the median, prices read 17 Nov 2026, before shipping. These are research-market prices for the amounts in published sources, not a recommended dose.
What is the cheapest Retatrutide per mg right now?
The lowest in-stock price is $6.25 per mg across 2 vendors (median $8.50 over 7 offers). The Retatrutide page lists every offer with its source date.
Where do these Retatrutide doses come from?
Each row is a dose from a published label or study, linked to its source. PeptideTech lists only sourced doses and does not recommend any; Investigational and not approved anywhere as of 2026-11-04; phase 3 TRIUMPH-1 and TRIUMPH-2 (2026) tested 4, 9 and 12 mg once weekly for 80 weeks.

Supplier links on the compound page can be affiliate links; they never affect prices shown or their order.